New Treatment For Macular Degeneration
Age-related macular degeneration or AMD refers to an eye condition which affect the macula, a tiny part of the retina at the back of the human eye. The macula is critical in perceiving details and colour. The risk of developing this defect increases with age, with the disease common in people beyond their sixties. The disease also impairs central vision, making it hard for older people to perceive objects directly in front of them. There are two types of AMD, 'wet' and 'dry' AM, depending on the processes occurring within the patient's eye.
Thanks to the rapid advancement in the medical field, treating 'incurable' diseases has become a more realistic goal. This can be attributed to technological developments in medicine, such as new breakthroughs in stem cell therapy. One application of this is the stem cell treatments is for macular degeneration treatment. This therapy has been tried and tested in leading medical research centers in the world. While adhering to proper ethical standards, stem cells macular degeneration treatment has improved the vision of many needy patients.
Macular degeneration stem cell treatment begins by the extraction of stem cells from the patient. The cells are found abundantly in the bone marrow of the hip bone (iliac crest) or abdominal fat cells (adipose). After extraction, the cells are re-injected. The cells have the rare ability to transform themselves into numerous other cell types. In addition, stem cells can regenerate most damaged tissues. These capabilities have been exploited by doctors in the stem cell treatment for macular degeneration.
This highly innovative macular degeneration stem cell treatment takes advantage of the potential of every patient's body to trigger cell regeneration. One of the most read success stories involving use of stem cells for macular degeneration treatment is that of a forty five year old lady who had unsuccessfully gone through several therapies to treat the disease. This included a couple of photodynamic laser treatments and two lucentris intra vitreo injections, without results. She finally opted to try macular degeneration stem cell treatment, the results which were outstanding. Just after two weeks, she recorded significant visual improvement.
The first step towards making the dream of using stem cells for macula degeneration treatment a reality was a demonstration by researchers that retinal cells could be recreated using human induced pluripotent stem (hiPS) cells which mimic the retinal pigment epithelium (RPE) cells that die to cause visual impairment. For the transplant to be viable, doctors must first find a way to program hiPS cells to transform to RPE cells.
Stem cells macular degeneration treatment is no doubt a better and less invasive type of treatment compared to the common injections and numerous surgeries current patients have to undertake. Just a single adult stem cell can be used to regenerate healthy cells to treat are-related macular degeneration. Despite many stem cell treatments being purely experimental, macular degeneration stem cell treatment is not. It satisfies all tenets of medical ethics, providing patients of AMD with a more promising option than those currently available. There is no need to suffer with this modern treatment method available.